Epilepsy is a condition that affects millions of people worldwide. Sudden unexpected death in epilepsy (SUDEP) is responsible for approximately 18 percent of epilepsy-related deaths. While many different factors are believed to increase the SUDEP risks, some them include the early onset of epilepsy, poor drug compliance and age. Still, there are definitely other significant factors that have not been confirmed yet. More research needs to be conducted so that scientists can better predict who is at higher risks to suffer from SUDEP.
For example, Dr. Shane Delamont and colleagues at King’s College Hospital performed a previous study which found that after some seizures, certain people had altered EEG recordings. This information had them wondering if those alterations (depressions) impacted how the patient’s heart functioned and how they breathed. This new grant will help the researchers study these depressions more intensely. The goal with this study is to see if it may someday be possible to know if patients who experience depressions in their brain activity after having a seizure are more susceptible to SUDEP.
Epilepsy affects millions of people worldwide. The condition is often treated with anti-seizure medications like Topamax. Topamax is a common drug used to prevent seizures, but it is also dangerous to use for women who are pregnant or thinking of becoming pregnant. Topamax has been linked to an increased risk of suicide and suicidal thoughts as well as birth defects in women whose babies are exposed to the drug in-utero. Some of those birth defects linked to Topamax use during pregnancy include cleft lips, cleft palates, genital defects and other birth malformations.
If your baby was born with birth defects after in-utero exposure to Topamax, contact attorney Greg Jones today for a free consultation. I am experienced at fighting Topamax lawsuits and may be able to help you recover money for your child’s injuries.